Varian, Inc.
Palo Alto, CA 94304
Dissolution Apparatus supports manual and automated testing.
Designed for testing tablets, capsules, and other dosage forms, Model 708-DS features traditional water bath and TruAlign(TM) vessels. System supports several automation options, including automated media temperature sensing, dosage delivery, and sampling. Integration with Varian UV or LC Dissolution Systems accelerates sample analysis, while minimizing potential for sample handling errors.
Read More »Pre-Assembled Cartridges speed oligonucleotide synthesis.
StratoSpheres(TM) DNA Synthesis Cartridges produce small to medium sized oligonucleotide strands required for use in DNA amplification, sequencing, and hybridization. Polystyrene packing provides high-throughput synthesis capabilities, while hydrophobic nature promotes production efficiency by maximizing yield of full length product. Two synthesis scales, 40 and 200 nmol, enable biochemists to...
Read More »GE Healthcare and Varian, Inc. Announce Pre-Clinical Magnetic Resonance Imaging (MRI) System
PALO ALTO, Calif., May 12 / / - GE Healthcare (NYSE: GE) and Varian, Inc. (NasdaqGS: VARI) announce the availability of the Discovery(TM) MR901, a new pre-clinical 7T magnetic resonance imaging (MRI) system which provides new capabilities for a broad range of research objectives. The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific...
Read More »Vacuum Gauge Controller is expandable.
Suited for situations requiring multi-point measurement and tracking of pressure, XGS-600(TM) can operate, display, and process readings from hot filament and cold cathode high-vacuum gauges (including ultra high vacuum) as well as convection roughing gauges. Unit comes in half-rack package and communicates readings/status via serial communications and set-point outputs. Used for data logging and...
Read More »X-Ray Diffractometer performs single crystal analysis.
Used for study challenging samples in small molecule and protein crystallography, SuperNova(TM) includes co-mounted, high-intensity X-ray micro-sources of molybdenum and copper wavelengths. Intensity of X-ray radiation placed on sample from dual Nova(TM) and Mova(TM) X-ray micro-sources promotes resolution and throughput. Along with Atlas CCD, system features AutoChem software for automated...
Read More »Turbomolecular Pumping System delivers portable, dry vacuum.
Available in benchtop and mobile models, TPS-compact provides plug-and-play, hydrocarbon-free, ultra-high vacuum pumping. Portable, integrated system is powered by Turbo-V 81 MacroTorr(TM) or Turbo-V 301 Navigator(TM) pumps, including control and communications software, and backed by Varian IDP-3 Dry Scroll primary pump with maximum weight of 42.11 lb. System includes display that shows gauge...
Read More »Mass Spectrometer is available with nano-LC option.
Combination of 216-LC nano-liquid chromatography option and 920-MS Triple Quadrupole Fourier Transform Mass Spectrometer promotes sensitivity and consistent data for researchers involved in proteomics research. With splitless design, 216-LC delivers nanoliter flows to mass spectrometer without discarding large fraction of solvent. More precise mixing of binary gradients, controlled by one flow...
Read More »Capillary Columns suited for high temperature GC and GC/MS.
Resistant to damage under extreme operating conditions, VF-5ht UltiMetal(TM) Column allows users to analyze samples at temperatures up to 450°C. Based on SS capillary, it addresses several problems associated with fused silica columns. Column can be used for separation of high boiling mixtures such as long chain hydrocarbons, polymers, plastics, waxes, heavy polyaromatic hydrocarbons, tars,...
Read More »FT-IR Spectrometer suits wide range of applications.
Including FT-IR (Fourier Transform Infrared) spectrometers, microscopes, and imaging solutions, Varian 600-IR Series provides analytical tool to identify/characterize samples in applications ranging from QA/QC testing of raw materials in pharmaceutical laboratories to detection of trace amounts of explosives/narcotics in forensic analysis. It can reveal chemical fingerprint of material, even in...
Read More »Ion Trap Mass Spectrometers are offered in 3 versions.
Series 200-MS ion trap mass spectrometers includes 240-MS, which features choice of ionization modes and MS/MS scanning options to allow accurate identification and quantification of trace analytes, even in presence of complex matrices. The 220-MS offers analytical capabilities with chemical ionization and MS/MS options for increased sensitivity and selectivity in range of configurations, while...
Read More »Varian Establishes Direct Operation in Kenya
PALO ALTO, California and NAIROBI, Kenya, Nov. 26, 2019 /PRNewswire/ -- At a grand opening ceremony attended by local dignitaries (H.E. Governor Prof. Anyan'g Nyong'o – Governor of Kisumu County, Vice Chairman – CoG Health Committee; Hon. Dr. Swarup Mishra Kiprop Arap Chelulei – MP – Kesses, Group Chairman, Founder Mediheal Hospitals, Vice Chairman - Parliament Health...
Read More »Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
Palo Alto, Calif., Nov. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian was ranked number three in the Healthcare Equipment and Services Industry and number 39 on this year's overall list for outperforming its peers...
Read More »Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Ca
PALO ALTO, Calif., Nov. 6, 2019 /PRNewswire/ -- In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support its efforts to develop patient-centered quality measures for cancer care. This year, there were an estimated 58,000 new cancer cases in the state of...
Read More »Varian Names Anshul Maheshwari Vice President Investor Relations
Palo Alto, Calif., Oct. 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries should be directed to Mr. Maheshwari. Prior to joining Varian in July 2018, Mr. Maheshwari was the assistant treasurer of Bechtel Corporation, where he had...
Read More »Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components
PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019. "We are thankful for the USTR and U.S. government's continued recognition of...
Read More »Varian Ranked Highest in Survey of US Radiation Oncology Professionals
PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally, Varian's Net Promotor Score improved from 71 in 2018 to 78 in 2019, and again was the highest among industry competitors. Net Promotor Scores represents the...
Read More »Varian Announces Immaterial Impact of Newly Proposed Tariffs
PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion in Chinese imports beginning September 1, 2019. Varian estimates these newly proposed...
Read More »Varian to Provide Mobile Technology to Cancer Patients Across Tennessee
PALO ALTO, Calif., June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased participation in their treatment, Varian (NYSE: VAR) today announced its collaboration with Tennessee Oncology for the implementation of Noona®, a software application for managing patient symptoms and capturing patient reported outcomes (PROs) in cancer care. As part of this collaboration,...
Read More »Varian Completes Acquisition of Cancer Treatment Services International
PALO ALTO, Calif., June 17, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes during the closing period to the original agreement announced on May 20, 2019. To view the original announcement,...
Read More »Varian Expands Cancer Care Solutions Portfolio with Interventional Oncology Acquisitions
Palo Alto, Calif., June 10, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions. Endocare is a leading provider of hardware and software solutions supporting cryoablation and microwave ablation, and Alicon, a leader in embolic therapy...
Read More »
